Saturday 17 October 2026 Export HRTX’s income statement to Excel — free account

Heron Therapeutics, Inc.

Heron Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $154.9 million, up 7.36% from fiscal 2024. In the quarter to June 2026, revenue grew 1.25%, EPS fell 93.6%, free cash flow grew 78.8% and total debt fell 18.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

0.36 0.02 −5.26%

Follow HRTX

Alert me

Market cap: $71.5M
P/E: 0.0×
Fwd P/E: −6.6×
Dividend yield: —
F-score: 4/9
Altman Z: −8.84
Beneish M: −2.40
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	2	3	4	5	+8 more TTM periods Free account
ROE Full definition →	318.21%	303.85%	198.30%	82.34%
ROA Full definition →	(14.06%)	(12.84%)	(8.26%)	(5.78%)
ROIC Full definition →	(6.35%)	(6.17%)	(1.46%)	1.01%
Return on Tangible Assets Full definition →	(22.77%)	(20.56%)	(13.08%)	(8.89%)
Average Days of Receivables Full definition →	216.26	202.69	211.09	190.73
Free Cash Flow per Share Full definition →	(0.06)	(0.11)	(0.17)	(0.18)
Free Cash Flow Full definition →	(12.09)	(20.80)	(27.81)	(31.03)
Capital Expenditures Full definition →	(0.48)	(0.54)	(0.22)	(0.85)
Other line items
Cash ROIC Full definition →	(6.29%)	(10.64%)	(13.79%)	(14.78%)
Accounts Receivable Turnover Full definition →	1.78	1.86	1.84	2.09
Accounts Payable Turnover Full definition →	3.82	4.09	3.99	3.64
Inventory Turnover Full definition →	0.55	0.58	0.57	0.70
Average Days of Payables Full definition →	93.91	75.22	79.40	108.42
Days of Inventory on Hand Full definition →	730.80	775.98	818.74	631.78
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	8.14%	8.32%	8.02%	7.65%
Selling, General and Administrative Expense of Revenue Full definition →	69.12%	69.74%	66.92%	65.24%
Share Based Compensation of Revenue Full definition →	7.40%	7.17%	6.67%	6.74%
Operating CF/Net income Full definition →	0.34	0.65	1.37	2.22
Depreciation/Fixed assets Full definition →	0.21	0.21	0.19	0.17
Capex/Depreciation Full definition →	(0.20)	(0.22)	(0.09)	(0.38)
Revenue per Share Full definition →	0.79	0.79	0.93	0.91
Operating CF per Share Full definition →	(0.06)	(0.11)	(0.17)	(0.18)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.01

Show all line items

Columns are period end dates

Stockrow Weekly